Xencor (XNCR) Current Taxes (2016 - 2026)

Xencor's (XNCR) quarterly Current Taxes came in at $841000.0 in Q1 2026, down 76.57% on a QoQ basis from $3.6 million in Q4 2025.

Xencor (XNCR) Current Taxes (2016 - 2026) Analysis & Trends

Xencor (XNCR) has 8 years of Current Taxes data on file, last reported at $841000.0 in Q1 2026.

On a quarterly basis, Current Taxes changed N/A year-over-year to $841000.0 in Q1 2026; TTM through Mar 2026 was $841000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $3.6 million, changed N/A from the prior year.
Current Taxes for Q1 2026 stood at $841000.0, down from $3.6 million in the prior quarter.
Over the last five years, Current Taxes for XNCR reached as high as $5.3 million in Q4 2023 and fell as low as $388000.0 in Q3 2022.
Historically, Current Taxes has averaged $3.1 million across 5 years, with a median of $3.6 million in 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	63.52 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	49.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Xencor	1.47 Bn	1.09 Bn	-	841,000.00

Download Data